Par Drugs and Chemicals quarterly results and financials

Par Drugs and Chemicals (PAR)₹113.17+4.99%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (standalone), Par Drugs and Chemicals reported sales of ₹31.18 Cr, up 20.2% from Jun 2025, and net profit of ₹4.70 Cr, up 41.6% year on year. For the year to Mar 2026, sales were ₹104 Cr and net profit ₹12.94 Cr.

Sales (Jun 2026): ₹31.18 Cr
Net profit (Jun 2026): ₹4.70 Cr
Sales (FY Mar 2026): ₹104 Cr
Net profit (FY Mar 2026): ₹12.94 Cr
EPS (Jun 2026): ₹3.82
Borrowings (Mar 2026): ₹0 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Par Drugs and Chemicals quarterly results

₹ crore unless stated; each column is a quarter.

Par Drugs and Chemicals Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	25.77	23.90	22.74	22.54	34.55	21.30	22.26	25.95	28.56	29.22	19.53	31.18
Expenses	18.48	18.70	16.66	18.31	23.15	19.89	19.82	22.42	22.50	23.22	18.10	24.82
Operating Profit	7.34	5.22	6.09	4.23	11.37	1.42	2.42	3.55	6.04	6.03	1.43	6.35
OPM %	28.5%	21.8%	26.8%	18.8%	33.0%	6.7%	10.9%	13.7%	21.2%	20.6%	7.4%	20.4%
Other Income	0.04	0.22	−0.04	0.06	1.01	0.26	0.78	1.83	0.47	1.32	0.35	0.93
Interest	0.02	0.01	0.04	0.01	0.02	0.00	0.01	0.03	0.04	0.00	0.03	0.01
Depreciation	0.86	0.88	0.90	0.89	0.90	0.92	0.91	0.89	0.93	0.92	0.92	0.95
Profit before tax	6.54	4.58	5.12	3.40	11.50	0.79	2.29	4.49	5.56	6.45	0.84	6.34
Tax %	25.2%	25.1%	27.2%	25.0%	25.1%	24.3%	27.6%	25.6%	25.5%	25.4%	−3.6%	25.5%
Net Profit	4.87	3.41	3.71	2.52	8.57	0.57	1.64	3.32	4.12	4.79	0.84	4.70
EPS (Rs)	3.96	2.77	3.01	2.05	6.98	0.46	1.33	2.70	3.35	3.89	0.68	3.82

Par Drugs and Chemicals profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Par Drugs and Chemicals Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	32.89	48.85	41.85	45.84	55.82	60.80	74.68	95.57	95.68	101	104	108
Expenses	25.92	39.83	33.90	37.89	45.81	44.87	58.75	77.77	72.73	80.67	86.69	88.64
Operating Profit	6.98	7.97	7.98	7.98	8.97	15.94	15.95	17.95	22.94	19.93	16.95	19.85
OPM %	22.0%	17.0%	19.1%	18.0%	17.1%	26.0%	22.0%	19.0%	24.1%	19.1%	17.1%	18.3%
Other Income	0.00	0.00	0.00	0.00	0.00	1.99	0.00	0.00	0.00	1.99	3.99	3.07
Interest	4.01	1.99	1.99	2.01	0.99	0.99	0.00	0.00	0.00	0.00	0.00	0.08
Depreciation	2.99	2.99	3.01	2.99	2.99	2.99	3.01	2.99	3.01	3.99	3.99	3.72
Profit before tax	1.01	2.99	3.01	3.01	6.01	15.02	13.01	15.02	20.01	18.02	17.02	19.19
Tax %	58.0%	41.9%	41.9%	23.9%	20.9%	21.0%	27.0%	25.0%	26.0%	26.0%	23.9%	—
Exceptional items	0.00	0.00	0.00	0.00	0.01	1.52	0.00	0.10	0.00	0.78	0.00	—
Net Profit	0.00	1.99	1.99	2.99	4.98	11.96	8.97	10.96	13.96	12.96	12.94	14.45
EPS (Rs)	0.77	3.42	2.77	2.78	3.86	9.43	7.47	9.19	11.75	10.84	10.63	11.74
Dividend payout %	0.0%	0.0%	0.0%	0.0%	32.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Par Drugs and Chemicals balance sheet

₹ crore, at each year end.

Par Drugs and Chemicals Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	3.01	3.01	3.01	3.01	4.01	6.03	6.02	12.05	12.04	12.05	12.04	12.04
Reserves	9.02	9.01	11.00	12.02	25.05	34.11	46.13	48.10	59.14	73.21	87.09	100
Borrowings	38.15	36.13	31.11	29.10	12.04	6.03	8.03	0.00	0.00	0.00	0.00	0.00
Other Liabilities	9.05	10.05	12.06	10.05	11.06	13.06	16.08	19.09	18.09	16.08	20.10	17.08
Total Liabilities	59.23	58.20	56.18	54.18	51.16	60.23	76.26	79.24	89.27	102	119	129
Fixed Assets	45.19	43.17	42.14	39.14	36.11	34.14	30.11	34.10	38.11	41.13	39.16	36.15
CWIP	0.00	0.00	0.00	0.00	0.00	1.01	5.01	0.00	0.00	0.00	0.00	1.01
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	24.95	26.96
Other Assets	13.04	15.03	14.04	15.04	15.05	25.08	42.14	44.14	50.16	60.21	55.12	65.22
Inventories	3.98	5.59	4.00	4.08	4.30	2.93	3.01	4.72	5.39	4.19	6.12	5.38
Trade receivables	7.55	7.40	8.14	8.75	8.56	12.42	12.50	18.54	17.01	13.76	16.78	12.07
Cash & equivalents	0.02	0.94	0.01	0.05	0.02	7.37	21.17	16.20	22.25	36.68	27.59	41.81
Total Assets	59.23	58.20	56.18	54.18	51.16	60.23	76.26	79.24	89.27	102	119	129

Par Drugs and Chemicals cash flow

₹ crore, for each year.

Par Drugs and Chemicals Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	9.01	6.99	8.99	3.99	1.99	7.99	11.99	7.99	12.99	19.97	15.98	15.98
Cash from investing activity	0.00	0.00	−1.99	−0.99	0.00	−1.01	0.00	−2.99	−7.01	−5.99	−24.99	−1.99
Cash from financing activity	−9.04	−5.02	−8.03	−4.01	−2.01	1.01	2.01	−10.04	0.00	0.00	0.00	0.00
Net cash flow	−0.99	0.99	−0.99	0.00	0.00	6.99	13.96	−4.99	5.99	13.97	−8.98	13.97
Capex	0.36	0.14	1.80	0.63	0.33	1.55	5.04	3.19	7.61	6.07	1.22	1.95
Free cash flow	8.98	5.99	6.99	3.99	1.99	5.98	11.97	3.99	5.98	13.98	14.97	13.98
CFO / OP %	127.0%	91.1%	116.0%	59.0%	34.0%	90.0%	98.1%	66.0%	97.1%	108.0%	106.0%	125.1%

Par Drugs and Chemicals ratios

Working-capital days and returns, by year.

Par Drugs and Chemicals Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	82	80	60	74	66	80	74	89	64	51	59	41
Inventory days	110	157	68	82	80	44	49	59	48	44	57	44
Days payable	185	184	136	108	95	97	113	136	74	59	105	70
Cash conversion cycle	10	57	−5	51	55	30	13	14	40	40	15	19
Working capital days	60	65	−47	−27	12	38	23	60	49	39	38	30
ROCE %	10.0%	9.0%	12.0%	11.0%	12.0%	16.0%	25.0%	22.0%	23.0%	25.0%	18.0%	17.0%

Par Drugs and Chemicals: frequently asked questions

What are the latest quarterly results of Par Drugs and Chemicals?

For the Jun 2026 quarter, Par Drugs and Chemicals reported sales of ₹31.18 Cr, up 20.2% year on year and net profit of ₹4.70 Cr, up 41.6% year on year. The operating margin was 20.4%.

What is the annual revenue of Par Drugs and Chemicals?

Par Drugs and Chemicals' sales for the year to Mar 2026 were ₹104 Cr; over the last twelve months they were ₹108 Cr.

What is the net profit of Par Drugs and Chemicals?

Net profit for the year to Mar 2026 was ₹12.94 Cr, and ₹14.45 Cr over the last twelve months. Earnings per share over the same trailing period were ₹11.74.

How much debt does Par Drugs and Chemicals have?

Par Drugs and Chemicals reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹41.81 Cr.

What is the free cash flow of Par Drugs and Chemicals?

Cash from operations was ₹15.98 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹13.98 Cr.

Loading…